Enerion, 200 mg 20 pcs.

The drug Enerion is a synthetic compound similar in structure to thiamine.

The sulbutiamine molecule has an open thiazole cycle, an additional disulfide bond and a lipophilic ester.

This modification makes it quickly absorbed from the gastrointestinal tract and easily passes through the GEB.

In contrast to thiamine, it is able to accumulate in cells of the reticular formation, hippocampus and dentate gyrus, as well as in Purkinje fiber cells and cerebellar granular layer cells of the cerebellar cortex.

Anerion improves coordination of movements and increases resistance to physical stress, increases resistance of cortical structures to repetitive hypoxia.

Indications

Symptomatic treatment of functional asthenia.

Pharmacological effect

The drug Enerion is a synthetic compound similar in structure to thiamine.

The sulbutiamine molecule has an open thiazole ring, an additional disulfide bond and a lipophilic ester.

Thanks to this modification, it is quickly absorbed from the gastrointestinal tract and easily penetrates the BBB.

Unlike thiamine, it can accumulate in the cells of the reticular formation, the hippocampus and the dentate gyrus, as well as in the cells of Purkinje fibers and the glomeruli of the granular layer of the cerebellar cortex.

While taking Enerion, coordination of movements improves and resistance to physical stress increases, and the resistance of cerebral cortex structures to repeated hypoxia increases.

Special instructions

The excipients of Enerion include lactose monohydrate. As a result, this drug is not recommended for use in persons with lactose intolerance, galactosemia, or glucose/galactose malabsorption syndrome.

Impact on the ability to drive a car and perform work requiring high speed psychomotor reactions. No effect.

Active ingredient

Sulbutiamine

Composition

Active substance:

sulbutiamine 200 mg,

Excipients:

corn starch – 12 mg;

dried starch paste – 40 mg;

glucose (dextrose) anhydrous – 20 mg;

lactose monohydrate – 65.5 mg;

magnesium stearate – 3.5 mg;

talc – 9 mg,

Shell:

sodium bicarbonate – 0.603 mg; sodium carboxymethylcellulose – 0.556 mg; white beeswax – 0.201 mg; titanium dioxide (E171) – 8.43 mg; ethylcellulose – 0.485 mg; Sunset yellow FCF, E110 – 3 mg; glycerol monooleate – 0.242 mg; polysorbate 80 – 0.302 mg; povidone – 0.692 mg; sucrose – 106.956 mg; anhydrous colloidal silicon dioxide (Aerosil 130) – 0.404 mg, talc – 28.21 mg.

Pregnancy

According to the results of clinical studies, the drug does not affect fetal development.

However, due to the lack of sufficient clinical data, Enerion is not recommended for use during pregnancy, as well as during breastfeeding, because It is currently unknown whether sulbutiamine is able to pass into breast milk.

Contraindications

Hypersensitivity to any of the components of the drug Enerion.

With caution: persons under 18 years of age (the drug is not recommended for use due to lack of clinical data).

Side Effects

Allergic reactions (the presence of Sunset yellow dye in the drug), digestive disorders, psychoneurological reactions (tremor, headache, agitation, general malaise).

Overdose

Symptoms: excitement with symptoms of euphoria and tremors of the limbs are transient in nature and do not require special treatment.

Storage conditions

At a temperature not exceeding 25 °C

Shelf life

3 years

Manufacturer

Servier Industry Laboratories, France